{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:49:19Z","timestamp":1790264959857,"version":"4.1.0"},"reference-count":198,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jaut.2017.05.008","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T10:16:36Z","timestamp":1497003396000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"special_numbering":"C","title":["Cardiovascular disease in systemic lupus erythematosus: A comprehensive update"],"prefix":"10.1016","volume":"82","author":[{"given":"Mayra","family":"Giannelou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio P.","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2017.05.008_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrneph.2017.51","article-title":"The immunology of atherosclerosis","volume":"13","author":"Gistera","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jaut.2017.05.008_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.06.010","article-title":"Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus","volume":"121","author":"Salmon","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib3","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jaut.2017.05.008_bib4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/rheumatology\/39.4.353","article-title":"Systemic lupus erythematosus: a model for atherogenesis?","volume":"39","author":"Manzi","year":"2000","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0961203307077987","article-title":"Current causes of death in systemic lupus erythematosus in Europe, 2000\u20132004: relation to disease activity and damage accrual","volume":"16","author":"Nossent","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/000331978503600705","article-title":"Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients","volume":"36","author":"Badui","year":"1985","journal-title":"Angiology"},{"issue":"Suppl 13","key":"10.1016\/j.jaut.2017.05.008_bib9","first-page":"223","article-title":"Morbidity in systemic lupus erythematosus","volume":"14","author":"Gladman","year":"1987","journal-title":"J.\u00a0Rheumatol. Suppl."},{"key":"10.1016\/j.jaut.2017.05.008_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus","volume":"93","author":"Petri","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.autrev.2004.04.002","article-title":"Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus","volume":"3","author":"Borchers","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.05.008_bib12","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1097\/MD.0000000000001183","article-title":"Cardiovascular events in systemic lupus erythematosus: a nationwide study in Spain from the RELESSER registry","volume":"94","author":"Fernandez-Nebro","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jaut.2017.05.008_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijcard.2014.08.006","article-title":"Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies","volume":"176","author":"Lin","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2017.05.008_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/acr.23018","article-title":"Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study","volume":"69","author":"Avina-Zubieta","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2016-210973","article-title":"Stroke in systemic lupus erythematosus: a Swedish population-based cohort study","author":"Arkema","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.05.008_bib17","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib18","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/rheumatology\/kev198","article-title":"Coronary calcification in SLE: comparison with the multi-ethnic study of atherosclerosis","volume":"54","author":"Kiani","year":"2015","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000136807.78534.50","article-title":"Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women","volume":"110","author":"El-Magadmi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2017.05.008_bib20","first-page":"292","article-title":"Brachial endothelial function is impaired in patients with systemic lupus erythematosus","volume":"29","author":"Lima","year":"2002","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/0003319715613917","article-title":"Early vascular aging in normotensive patients with systemic lupus erythematosus: comparison with young patients having hypertension","volume":"67","author":"Morreale","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.jaut.2017.05.008_bib22","doi-asserted-by":"crossref","first-page":"765253","DOI":"10.1155\/2013\/765253","article-title":"Proximal aortic stiffness is increased in systemic lupus erythematosus activity in children and adolescents","volume":"2013","author":"El Gamal","year":"2013","journal-title":"ISRN Pediatr."},{"key":"10.1016\/j.jaut.2017.05.008_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0961203308097571","article-title":"Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients","volume":"18","author":"Cacciapaglia","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.autrev.2010.05.018","article-title":"Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: are they early markers of subclinical atherosclerosis?","volume":"9","author":"Zardi","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.05.008_bib25","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar4489","article-title":"Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events","volume":"16","author":"Frerix","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.008_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/0961203314537696","article-title":"The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients","volume":"23","author":"Eder","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib27","doi-asserted-by":"crossref","first-page":"e0152291","DOI":"10.1371\/journal.pone.0152291","article-title":"Relationship between QT interval length and arterial stiffness in systemic lupus erythematosus (SLE): a cross-sectional case-control study","volume":"11","author":"Rivera-Lopez","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2017.05.008_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/0961203308093554","article-title":"Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain","volume":"17","author":"Sabio","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ard.2006.054973","article-title":"High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors","volume":"66","author":"Chung","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/03009740903046668","article-title":"Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus","volume":"39","author":"Mok","year":"2010","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib31","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3899\/jrheum.081253","article-title":"Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus","volume":"36","author":"Sabio","year":"2009","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/03009742.2013.803150","article-title":"Increased arterial stiffness is independently associated with metabolic syndrome and damage index in systemic lupus erythematosus patients","volume":"43","author":"Valero-Gonzalez","year":"2014","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib33","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/annrheumdis-2013-203933","article-title":"Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort","volume":"74","author":"Parker","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib34","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.11296","article-title":"Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study","volume":"48","author":"Bruce","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/acr.20343","article-title":"Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus","volume":"63","author":"Katz","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib36","first-page":"1194","article-title":"Impairment of arterial distensibility in premenopausal women with systemic lupus erythematosus","volume":"66","author":"Yildiz","year":"2008","journal-title":"Kardiologia Pol."},{"key":"10.1016\/j.jaut.2017.05.008_bib37","doi-asserted-by":"crossref","first-page":"e2177","DOI":"10.1097\/MD.0000000000002177","article-title":"Overweight is a major contributor to atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease: a cross-sectional controlled study","volume":"94","author":"Sacre","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jaut.2017.05.008_bib38","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.24469","article-title":"Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort","volume":"60","author":"Schanberg","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib39","article-title":"Insulin resistance in systemic lupus erythematosus patients: contributing factors and relationship with subclinical atherosclerosis","author":"Sanchez-Perez","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib40","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1749-6632.2010.05875.x","article-title":"Adipokines as novel biomarkers and regulators of the metabolic syndrome","volume":"1212","author":"Deng","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2017.05.008_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.atherosclerosis.2009.12.007","article-title":"Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus","volume":"210","author":"Reynolds","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaut.2017.05.008_bib42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0961203309103582","article-title":"Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis","volume":"18","author":"Chung","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib43","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/ard.2010.142737","article-title":"High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids","volume":"70","author":"McMahon","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3899\/jrheum.080503","article-title":"Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors","volume":"36","author":"Vadacca","year":"2009","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.38204","article-title":"A\u00a0panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus","volume":"66","author":"McMahon","year":"2014","journal-title":"Arthritis Rheumatol. (Hoboken, NJ)"},{"key":"10.1016\/j.jaut.2017.05.008_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0961203313517405","article-title":"Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients","volume":"23","author":"Parra","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib47","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/art.11260","article-title":"Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy","volume":"48","author":"Sella","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.11418","article-title":"Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus","volume":"50","author":"Selzer","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib49","first-page":"2458","article-title":"Predictors of carotid atherosclerosis in systemic lupus erythematosus","volume":"33","author":"Maksimowicz-McKinnon","year":"2006","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib50","first-page":"386","article-title":"Carotid plaques in patients with long-term lupus nephritis","volume":"28","author":"Gallelli","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib51","first-page":"522","article-title":"The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus","volume":"46","author":"Cypiene","year":"2010","journal-title":"Med. Kaunas. Lith."},{"key":"10.1016\/j.jaut.2017.05.008_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.autrev.2017.01.009","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis","volume":"16","author":"Tektonidou","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.05.008_bib53","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/rheumatology\/ker285","article-title":"Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus","volume":"50","author":"Kiani","year":"2011","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib54","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203306069972","article-title":"Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus","volume":"15","author":"de Leeuw","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/0961203309105876","article-title":"Metabolic syndrome in Argentinean patients with systemic lupus erythematosus","volume":"18","author":"Bellomio","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib56","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.101132","article-title":"Prevalence of and factors associated with hypertension in young and old women with systemic lupus erythematosus","volume":"38","author":"Sabio","year":"2011","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib57","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.semarthrit.2013.07.007","article-title":"Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal","volume":"43","author":"Tselios","year":"2014","journal-title":"Seminars Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib58","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.3899\/jrheum.150531","article-title":"Nighttime blood pressure patterns and subclinical atherosclerosis in women with systemic lupus erythematosus","volume":"42","author":"Sabio","year":"2015","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease\u2013six year follow-up experience. The Framingham Study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib60","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib61","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev.bi.46.070177.004341","article-title":"The low-density lipoprotein pathway and its relation to atherosclerosis","volume":"46","author":"Goldstein","year":"1977","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jaut.2017.05.008_bib62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000174169","article-title":"Role of dietary intervention in the primary prevention of coronary heart disease. Individuals with high-normal or elevated serum cholesterol levels should be placed on cholesterol-lowering diets","volume":"74","author":"Blum","year":"1987","journal-title":"Cardiology"},{"key":"10.1016\/j.jaut.2017.05.008_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/art.23353","article-title":"Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort","volume":"59","author":"Urowitz","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib64","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.semarthrit.2015.10.010","article-title":"Dyslipidemia in systemic lupus erythematosus: just another comorbidity?","volume":"45","author":"Tselios","year":"2016","journal-title":"Seminars Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib65","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/1529-0131(200005)43:5<1033::AID-ANR11>3.0.CO;2-B","article-title":"Chylomicron metabolism is markedly altered in systemic lupus erythematosus","volume":"43","author":"Borba","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib66","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/096120339700600610","article-title":"Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies","volume":"6","author":"Borba","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/VHRM.S17015","article-title":"Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus","volume":"7","author":"Olusi","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.jaut.2017.05.008_bib68","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.3899\/jrheum.091175","article-title":"Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus","volume":"37","author":"Gonzalez","year":"2010","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib69","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2012.08.029","article-title":"Complement system and small HDL particles are associated with subclinical atherosclerosis in SLE patients","volume":"225","author":"Parra","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaut.2017.05.008_bib70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar2471","article-title":"Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis","volume":"10","author":"Hahn","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.008_bib71","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.21976","article-title":"Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"54","author":"McMahon","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib72","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/art.24677","article-title":"Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus","volume":"60","author":"McMahon","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib73","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/acr.20076","article-title":"Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus","volume":"62","author":"Volkmann","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib74","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/rheumatology\/keg248","article-title":"Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"42","author":"Delgado Alves","year":"2003","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib75","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3899\/jrheum.150460","article-title":"Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review","volume":"43","author":"Tselios","year":"2016","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib76","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1002\/art.20622","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events","volume":"50","author":"Toloza","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib77","doi-asserted-by":"crossref","first-page":"R186","DOI":"10.1186\/ar2878","article-title":"Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study","volume":"11","author":"Gustafsson","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.008_bib78","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0025-6196(12)61007-6","article-title":"Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension","volume":"66","author":"Homer","year":"1991","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2017.05.008_bib79","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/rheumatology\/kem002","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype","volume":"46","author":"Ahmad","year":"2007","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib80","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib81","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.autrev.2017.02.005","article-title":"Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus","volume":"16","author":"Parodis","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.05.008_bib82","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib83","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/01.ATV.14.7.1080","article-title":"High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis","volume":"14","author":"Falcon","year":"1994","journal-title":"Arteriosclr Thromb. J. Vasc. Biol."},{"key":"10.1016\/j.jaut.2017.05.008_bib84","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(95)90008-X","article-title":"Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?","volume":"345","author":"den Heijer","year":"1995","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jaut.2017.05.008_bib85","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"Jama"},{"key":"10.1016\/j.jaut.2017.05.008_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2003.11.022","article-title":"Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence","volume":"176","author":"Durga","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaut.2017.05.008_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.06.009","article-title":"Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: a mechanistic and clinical perspective","volume":"78","author":"Santilli","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.jaut.2017.05.008_bib88","doi-asserted-by":"crossref","first-page":"872","DOI":"10.5858\/2007-131-872-HATAO","article-title":"Hyperhomocysteinemia and thrombosis: an overview","volume":"131","author":"Eldibany","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib89","first-page":"76","article-title":"Homocysteine serum levels are increased and correlate with disease severity in patients with lupus erythematosus","volume":"34","author":"Bonciani","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib90","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/acr.22340","article-title":"Relationship between homocysteine levels and hypertension in systemic lupus erythematosus","volume":"66","author":"Sabio","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib91","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/art.21172","article-title":"Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors","volume":"53","author":"Afeltra","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib92","first-page":"111","article-title":"A\u00a0clinical study of hyperhomocysteinemia in rheumatological diseases","volume":"44","author":"Xu","year":"2005","journal-title":"Zhonghua nei ke za zhi"},{"key":"10.1016\/j.jaut.2017.05.008_bib93","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/acr.20365","article-title":"Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis","volume":"63","author":"Rho","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib94","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/096120300678828226","article-title":"Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort","volume":"9","author":"Petri","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib95","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s100670200115","article-title":"Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients","volume":"21","author":"Refai","year":"2002","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib96","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2017.05.008_bib97","first-page":"184","article-title":"Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench","volume":"66","author":"Von Feldt","year":"2008","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib98","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/art.21967","article-title":"Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus","volume":"54","author":"Von Feldt","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib99","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1002\/art.22924","article-title":"Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus","volume":"56","author":"Roman","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib100","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.104349","article-title":"Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study","volume":"69","author":"Rua-Figueroa","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib101","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/acr.22271","article-title":"Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus","volume":"66","author":"Lertratanakul","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib102","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.27392","article-title":"Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients","volume":"62","author":"Perna","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib103","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3899\/jrheum.090306","article-title":"Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study","volume":"37","author":"Haque","year":"2010","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib104","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1002\/art.25019","article-title":"Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus","volume":"60","author":"Huang","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib105","doi-asserted-by":"crossref","first-page":"e0174572","DOI":"10.1371\/journal.pone.0174572","article-title":"Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: case control study of 281 SLE patients and 281 individually matched population controls","volume":"12","author":"Gustafsson","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2017.05.008_bib106","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D","article-title":"Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus","volume":"42","author":"Manzi","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib107","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3899\/jrheum.090824","article-title":"Noncalcified coronary plaque in systemic lupus erythematosus","volume":"37","author":"Kiani","year":"2010","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib108","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0961203315622822","article-title":"Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis","volume":"25","author":"Sharma","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib109","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/ard.62.11.1071","article-title":"Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus","volume":"62","author":"Doria","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib110","first-page":"8","article-title":"Impact of chronic glucocorticoid treatment on cardiovascular risk profile in patients with systemic lupus erythematosus","volume":"22","author":"Moya","year":"2016","journal-title":"J.\u00a0Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib111","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3899\/jrheum.150437","article-title":"Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy","volume":"43","author":"Durcan","year":"2016","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib112","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib113","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1177\/0961203311411347","article-title":"Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients","volume":"20","author":"Sazliyana","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib114","first-page":"325","article-title":"The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs","volume":"26","author":"Rahman","year":"1999","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.27289","article-title":"The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus","volume":"62","author":"Jung","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib116","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.mehy.2016.04.045","article-title":"Hydroxychloroquine, a promising choice for coronary artery disease?","volume":"93","author":"Sun","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jaut.2017.05.008_bib117","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.008_bib118","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1182\/blood-2007-05-089086","article-title":"Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis","volume":"110","author":"Denny","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.05.008_bib119","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.37.4.1075","article-title":"Vascular stiffness in women with systemic lupus erythematosus","volume":"37","author":"Selzer","year":"2001","journal-title":"Hypertens. (Dallas, Tex 1979)"},{"key":"10.1016\/j.jaut.2017.05.008_bib120","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/annrheumdis-2011-200071","article-title":"Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-\/-) mice","volume":"71","author":"van Leuven","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib121","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1007\/s00296-011-2048-y","article-title":"Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years","volume":"32","author":"Kiani","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2017.05.008_bib122","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/hmg\/ddn184","article-title":"A\u00a0risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5","volume":"17","author":"Sigurdsson","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2017.05.008_bib123","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2009.115535","article-title":"A\u00a0STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus","volume":"69","author":"Svenungsson","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib124","first-page":"131","article-title":"Mannose binding lectin gene polymorphism and preclinical carotid atherosclerosis in patients with systemic lupus erythematosus","volume":"17","author":"El-Sherif","year":"2010","journal-title":"Egypt. J. Immunol."},{"key":"10.1016\/j.jaut.2017.05.008_bib125","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1161\/CIRCULATIONAHA.108.808675","article-title":"MTHFR 677 C\u00a0>\u00a0T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis","volume":"119","author":"Antoniades","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2017.05.008_bib126","first-page":"1229","article-title":"Endothelial nitric oxide synthase and methylenetetrahydrofolate reductase gene polymorphisms are associated with endothelial dysfunction in young, healthy men","volume":"20","author":"Imamura","year":"2004","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.jaut.2017.05.008_bib127","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2004.06.003","article-title":"Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians","volume":"176","author":"Kelemen","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaut.2017.05.008_bib128","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.3899\/jrheum.080071","article-title":"Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus","volume":"35","author":"Summers","year":"2008","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib129","doi-asserted-by":"crossref","first-page":"e60430","DOI":"10.1371\/journal.pone.0060430","article-title":"BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-\/-) mice","volume":"8","author":"Kyaw","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2017.05.008_bib130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/1744666X.2017.1291343","article-title":"Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE)","volume":"13","author":"Stohl","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.05.008_bib131","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000092891.55157.A7","article-title":"Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis","volume":"108","author":"Karvonen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2017.05.008_bib132","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.20780","article-title":"Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations","volume":"52","author":"Frostegard","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib133","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00296-013-2875-0","article-title":"Higher circulating levels of OxLDL % of LDL are associated with subclinical atherosclerosis in female patients with systemic lupus erythematosus","volume":"34","author":"Ahmad","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2017.05.008_bib134","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/art.38703","article-title":"Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus","volume":"66","author":"Smith","year":"2014","journal-title":"Arthritis Rheumatol. (Hoboken, NJ)"},{"key":"10.1016\/j.jaut.2017.05.008_bib135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1191\/096120398678920262","article-title":"Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE","volume":"7","author":"Dinu","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib136","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/art.10542","article-title":"Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"46","author":"Delgado Alves","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib137","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/ken397","article-title":"Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus","volume":"48","author":"Batuca","year":"2009","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0961203306075802","article-title":"Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms","volume":"16","author":"Avalos","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib139","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1182\/blood-2007-05-092825","article-title":"Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis","volume":"111","author":"Margutti","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.05.008_bib140","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1002\/art.20564","article-title":"Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients","volume":"50","author":"Dieude","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib141","first-page":"413","article-title":"The role of endothelial cells in the pathogenesis of systemic lupus erythematosus","volume":"61","author":"Robak","year":"2007","journal-title":"Postepy Hig. i Med. doswiadczalnej (Online)"},{"key":"10.1016\/j.jaut.2017.05.008_bib142","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/rheumatology\/keq041","article-title":"Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies","volume":"49","author":"Duval","year":"2010","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib143","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clim.2004.02.015","article-title":"Endothelial cell activation by antiphospholipid antibodies","volume":"112","author":"Meroni","year":"2004","journal-title":"Clin. Immunol. Orl. Fla"},{"key":"10.1016\/j.jaut.2017.05.008_bib144","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.ATV.0000150415.18759.36","article-title":"Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus","volume":"25","author":"Cederholm","year":"2005","journal-title":"Arteriosclr, Thromb., Vasc. Biol."},{"key":"10.1016\/j.jaut.2017.05.008_bib145","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.thromres.2004.07.012","article-title":"The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): hopkins Lupus Cohort","volume":"114","author":"Petri","year":"2004","journal-title":"Thrombosis Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib146","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.22265","article-title":"Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus","volume":"54","author":"Farzaneh-Far","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib147","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(93)91213-6","article-title":"Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus","volume":"341","author":"Vaarala","year":"1993","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jaut.2017.05.008_bib148","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/01.ATV.21.2.269","article-title":"Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2)","volume":"21","author":"Hulthe","year":"2001","journal-title":"Arteriosclr, Thromb., Vasc. Biol."},{"key":"10.1016\/j.jaut.2017.05.008_bib149","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/clim.1998.4631","article-title":"Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus","volume":"90","author":"Lopes-Virella","year":"1999","journal-title":"Clin. Immunol. Orl. Fla"},{"key":"10.1016\/j.jaut.2017.05.008_bib150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.HYP.33.1.53","article-title":"Autoantibodies to OxLDL are decreased in individuals with borderline hypertension","volume":"33","author":"Wu","year":"1999","journal-title":"Hypertens. (Dallas, Tex 1979)"},{"key":"10.1016\/j.jaut.2017.05.008_bib151","doi-asserted-by":"crossref","first-page":"e37000","DOI":"10.1371\/journal.pone.0037000","article-title":"Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients","volume":"7","author":"Somers","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2017.05.008_bib152","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood-2010-03-274605","article-title":"Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease","volume":"116","author":"Lood","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.05.008_bib153","first-page":"4457","article-title":"The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction","volume":"185","author":"Thacker","year":"2010","journal-title":"J.\u00a0Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.jaut.2017.05.008_bib154","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/art.30165","article-title":"Interferon-alpha priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-alpha and atherosclerosis in lupus","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","article-title":"Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions","volume":"12","author":"Goossens","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.jaut.2017.05.008_bib156","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1161\/CIRCULATIONAHA.106.642801","article-title":"Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha","volume":"114","author":"Niessner","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2017.05.008_bib157","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00281-013-0375-7","article-title":"Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity","volume":"35","author":"Carmona-Rivera","year":"2013","journal-title":"Seminars Immunopathol."},{"key":"10.1016\/j.jaut.2017.05.008_bib158","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/BOR.0000000000000307","article-title":"Update on cardiovascular disease in lupus","volume":"28","author":"Lewandowski","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib159","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11739-016-1543-2","article-title":"An exploratory look at NETosis in atherosclerosis","volume":"12","author":"Mozzini","year":"2017","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.jaut.2017.05.008_bib160","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2003-09-3198","article-title":"Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity","volume":"103","author":"Rajagopalan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2017.05.008_bib161","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1002\/art.23035","article-title":"Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus","volume":"56","author":"Lee","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib162","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/ar2283","article-title":"Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus","volume":"9","author":"Moonen","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.008_bib163","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/ard.2006.065631","article-title":"Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus","volume":"66","author":"Westerweel","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2017.05.008_bib164","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S0140-6736(15)60398-1","article-title":"Role of vitamin D in endothelial function and endothelial repair in clinically stable systemic lupus erythematosus","volume":"385","author":"Reynolds","year":"2015","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jaut.2017.05.008_bib165","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair","volume":"111","author":"Schmidt-Lucke","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2017.05.008_bib166","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/rheumatology\/ket367","article-title":"Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus","volume":"53","author":"Castejon","year":"2014","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib167","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/cei.12651","article-title":"Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus","volume":"181","author":"Svenungsson","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.05.008_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.03.017","article-title":"Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus","volume":"153","author":"Gronwall","year":"2014","journal-title":"Clin. Immunol. Orl. Fla"},{"key":"10.1016\/j.jaut.2017.05.008_bib169","doi-asserted-by":"crossref","first-page":"R214","DOI":"10.1186\/ar3193","article-title":"Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus","volume":"12","author":"Anania","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.008_bib170","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2017.03.007","article-title":"The heartbreak of depression: 'Psycho-cardiac' coupling in myocardial infarction","volume":"106","author":"Headrick","year":"2017","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.jaut.2017.05.008_bib171","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2016_28","article-title":"Inflammation-associated Co-morbidity between depression and cardiovascular disease","volume":"31","author":"Halaris","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.jaut.2017.05.008_bib172","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.13081","article-title":"Sleep quality, clinical and psychological manifestations in women with systemic lupus erythematosus","author":"Moraleda","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib173","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12888-017-1234-1","article-title":"Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jaut.2017.05.008_bib174","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/acr.22992","article-title":"Depression and progression of subclinical cardiovascular disease in systemic lupus erythematosus","volume":"69","author":"Jorge","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib175","first-page":"673","article-title":"Cardiovascular disease and osteoporosis: balancing risk management","volume":"3","author":"Warburton","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.jaut.2017.05.008_bib176","first-page":"19","article-title":"The link between osteoporosis and cardiovascular disease","volume":"5","author":"Farhat","year":"2008","journal-title":"Clin. Cases Miner. Bone Metab. Off. J. Italian Soc. Osteoporos. Miner. Metab. Skeletal Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib177","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13075-015-0595-4","article-title":"Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study","volume":"17","author":"Ajeganova","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.008_bib178","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0961203314548247","article-title":"Carotid atherosclerosis is not associated with lower bone mineral density and vertebral fractures in patients with systemic lupus erythematosus","volume":"24","author":"Mendoza-Pinto","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib179","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0961203315608255","article-title":"Low bone mass and carotid atherosclerosis in lupus erythematosus patients from Granada, a city in the south of Spain","volume":"25","author":"Lopez-Robles","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib180","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/ard.2009.117200","article-title":"European League against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies","volume":"69","author":"Mosca","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib181","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.autrev.2010.12.008","article-title":"Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice","volume":"10","author":"Mosca","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.05.008_bib182","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib183","first-page":"340","article-title":"The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin","volume":"182","author":"Aprahamian","year":"2009","journal-title":"J.\u00a0Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.jaut.2017.05.008_bib184","first-page":"2729","article-title":"The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus","volume":"183","author":"Zhao","year":"2009","journal-title":"J.\u00a0Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.jaut.2017.05.008_bib185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0961203311422096","article-title":"Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial","volume":"21","author":"Juarez-Rojas","year":"2012","journal-title":"Lupus"},{"issue":"Suppl 2","key":"10.1016\/j.jaut.2017.05.008_bib186","first-page":"E1","volume":"14","author":"Graham","year":"2007","journal-title":"Eur. J. Cardiovasc. Prev. Rehab. Off. J. Eur. Soc. Cardiol. Work. Groups Epidemiol. Prev. Cardiac. Rehab. Exerc. Physiol."},{"key":"10.1016\/j.jaut.2017.05.008_bib187","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertens. (Dallas, Tex 1979)"},{"key":"10.1016\/j.jaut.2017.05.008_bib188","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/rheumatology\/ken208","article-title":"Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus\u2013results from LUMINA (LIX): a multiethnic US cohort","volume":"47","author":"Duran-Barragan","year":"2008","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.jaut.2017.05.008_bib189","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2012.14","article-title":"Accelerated atherosclerosis in patients with SLE\u2013mechanisms and management","volume":"8","author":"Skaggs","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.008_bib190","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.HYP.17.5.593","article-title":"Raynaud's phenomenon. An update","volume":"17","author":"Coffman","year":"1991","journal-title":"Hypertens. (Dallas, Tex 1979)"},{"key":"10.1016\/j.jaut.2017.05.008_bib191","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.amjcard.2006.09.125","article-title":"The inflammation hypothesis and its potential relevance to statin therapy","volume":"99","author":"Forrester","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jaut.2017.05.008_bib192","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/acr.20440","article-title":"Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jaut.2017.05.008_bib193","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.30645","article-title":"Use of atorvastatin in systemic lupus erythematosus in children and adolescents","volume":"64","author":"Schanberg","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.008_bib194","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard.2010.136762","article-title":"Lupus atherosclerosis prevention study (LAPS)","volume":"70","author":"Petri","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/0961203316662719","article-title":"Short-term atorvastatin therapy improves arterial stiffness of middle-aged systemic lupus erythematosus patients with pathological pulse wave velocity","volume":"26","author":"Castejon","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2017.05.008_bib196","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/annrheumdis-2012-202315","article-title":"Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein","volume":"73","author":"Ardoin","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.008_bib197","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar3020","article-title":"Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis","volume":"12","author":"Woo","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.008_bib198","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jama.2015.2274","article-title":"Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial","volume":"313","author":"Huo","year":"2015","journal-title":"Jama"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117303797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117303797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:54Z","timestamp":1760256954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841117303797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":198,"alternative-id":["S0896841117303797"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.05.008","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease in systemic lupus erythematosus: A comprehensive update","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}